Services on Demand
Journal
Article
Indicators
Cited by SciELO
Access statistics
Related links
Cited by Google
Similars in SciELO
Similars in Google
Share
Colombian Journal of Anestesiology
Print version ISSN 0120-3347
Abstract
MACHADO-ALBA, Jorge Enrique; SANCHEZ-MORALES, Leidy Viviana and RODRIGUEZ-RAMIREZ, Luisa Fernanda. Dipyrone-related granulocytopenia. Case report. Rev. colomb. anestesiol. [online]. 2018, vol.46, n.4, pp.327-330. ISSN 0120-3347. https://doi.org/10.1097/cj9.0000000000000053.
Introduction:
Dipyrone has been positioned in several countries as one of the first over-the-counter options for pain management. Its possible adverse effects are known worldwide; among them, agranulocytosis is the most lethal, with a mortality of approximately 10% and an associated risk of 1 per 1,000,000 patients.
Clinical findings, interventions, and outcomes:
A case of a patient who, after 23 days of using dipyrone for pain management, developed a progressive drop in leukocyte count. Other potential causes of the event were ruled out. After dipyrone discontinuation, leukocyte counts returned to their normal values.
Conclusion:
The probable diagnosis of granulocytopenia as a dipyrone-related adverse drug reaction was established. Although rare, dipyrone-related granulocytopenia, may occur in patients who use this medication for long periods.
Keywords : Dipyrone; Agranulocytosis; Pharmacovigilance; Adverse effects; Case Report.